BusinessPTC Therapeutics Authorizes Up to $500 Million in Share BuybacksBy Helena WardNov 3, 2026, 12:54 PM UTC
HealthPTC Therapeutics Raises 2026 Product Revenue Forecast After Sephience GrowthBy Naomi CalderOct 30, 2026, 3:29 AM UTC